Josephs K A, Holton J L, Rossor M N, Godbolt A K, Ozawa T, Strand K, Khan N, Al-Sarraj S, Revesz T
Department of Neurology, Mayo Clinic, Rochester, USA.
Neuropathol Appl Neurobiol. 2004 Aug;30(4):369-73. doi: 10.1111/j.1365-2990.2003.00545.x.
We set out to determine the frequency of the different pathologies underlying frontotemporal degeneration (FTD) in our brain bank series, by reviewing all cases of pathologically diagnosed FTD over the last 12 years. We identified and reviewed 29 cases of FTD and classified them using the most recent consensus criteria with further histological analysis of 6 initially unclassifiable cases. Detailed histological analysis of these 6 cases revealed variable numbers of ubiquitin-positive (tau and alpha-synuclein-negative) inclusions in 5 cases, consistent with the diagnosis of frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes (FTLD-U). As a consequence of the current re-evaluation, 18 (62%) of the 29 cases with FTD have underlying pathology consistent with FTLD-U. Therefore in our brain bank series of frontotemporal degeneration, most cases were non-tauopathies with FTLD-U accounting for 62% of all the diagnoses.
我们通过回顾过去12年中所有经病理诊断为额颞叶变性(FTD)的病例,来确定我们脑库系列中导致FTD的不同病理情况的发生率。我们识别并回顾了29例FTD病例,并使用最新的共识标准进行分类,对6例最初无法分类的病例进行了进一步的组织学分析。对这6例病例的详细组织学分析显示,5例中有数量不等的泛素阳性(tau和α-突触核蛋白阴性)包涵体,符合仅具有泛素免疫反应性神经元变化的额颞叶变性(FTLD-U)的诊断。由于目前的重新评估,29例FTD病例中有18例(62%)的潜在病理与FTLD-U一致。因此,在我们的额颞叶变性脑库系列中,大多数病例是非tau蛋白病,FTLD-U占所有诊断的62%。